Diomed Holdings Inc - Current report filing (8-K)
January 14 2008 - 3:48PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
January
14, 2008
Diomed
Holdings, Inc.
Delaware
|
000-32045
|
84-1480636
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
1
Dundee Park
Andover,
MA
|
01810
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(978-475-7771)
Item
7.01
Regulation
FD Disclosure
On
January 14, 2008, Diomed Holdings, Inc. (“Diomed”) issued a press release
disclosing that District Judge Maxine M. Chesney of the U.S. District Court
for
the Northern District of California has set June 23, 2008 as the date for the
commencement of trial in the ongoing patent infringement proceeding brought
by
VNUS Medical Technologies, Inc. against Diomed and its co-defendants,
Angio-Dynamics, Inc. and Vascular Solutions, Inc. A copy of this press release
is attached hereto as Exhibit 99.1.
Also
on
January 14, 2008, Diomed issued a second press release disclosing that District
Judge Nathaniel M. Gorton of the U.S. Federal District Court for the District
of
Massachusetts has set January 18, 2008 as the date to hear Diomed's request
for
a preliminary injunction against Total Vein Solutions in Diomed’s continuing
efforts to enforce its U.S. Patent Number 6,398,777, covering the endovascular
laser treatment of varicose veins. Diomed commenced legal action against Total
Vein Solutions seeking injunctive relief and damages for infringement of
Diomed's patent in 2004. A copy of this press release is attached hereto as
Exhibit 99.2
Item
9.01
Financial
Statements and Exhibits
99.1
|
Press
Release Issued January 14, 2008 regarding VNUS Trial
Scheduling
|
99.2
|
Press
Release Issued January 14, 2008 regarding Total Vein Solutions Preliminary
Injunction Hearing Scheduling
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
Diomed
Holdings, Inc.
(Registrant)
|
|
|
|
Date:
January
14, 2008
|
By:
|
/s/ DAVID
B.
SWANK
|
|
Name:
|
David
B. Swank
|
|
Title:
|
Chief
Financial Officer
|
99.1
|
Press
Release Issued January 14, 2008 regarding VNUS Trial
Scheduling
|
99.2
|
Press
Release Issued January 14, 2008 regarding Total Vein Solutions Preliminary
Injunction Hearing Scheduling
|
Diomed (AMEX:DIO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Diomed (AMEX:DIO)
Historical Stock Chart
From Jul 2023 to Jul 2024